Many pharmacologic therapies are being considered for the treatment and management of COVID-19, with ever-changing efficacy and safety-related evidence from clinical trials. To get an overview of the treatment guidelines for different types of COVID-19 patients, check out this infographic ! In continuation with this, here is the first set of guidelines on lopinavir/ritonavir included in the recent IDSA guidelines for treating and managing COVID-19. Guidelines for recommending the usage of the drug lopinavir/ritonavir in COVID-19 patients: The guidelines recommend against using lopinavir/ritonavir in patient groups at risk of having COVID-19.
Stay tuned for more insights on the recent updates on the guidelines for inhaled corticosteroids! Which of the drugs have you prescribed for managing mild/moderate COVID-19 patients? Share your views by commenting below! ##Reference## Adarsh…
